![]() |
市場調查報告書
商品編碼
1890755
脈搏血氧儀探頭市場規模、佔有率、成長及全球產業分析:按類型、應用和地區劃分的洞察與預測(2024-2032)Pulse Oximeter Probes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
隨著呼吸健康監測成為現代醫療保健系統的重要組成部分,全球脈搏血氧儀探頭市場持續擴張。 2024年,市場規模達到27億美元,主要驅動因素包括呼吸系統和心血管疾病的增加、外科手術數量的增長以及人口老化。非侵入性患者監測技術的進步和家庭醫療保健的興起也加速了產品的普及。預計到2025年,市場規模將成長至30.2億美元,反映出醫院、門診手術中心和家庭醫療保健機構的強勁需求。到2032年,市場規模預計將達到69.9億美元,預測期內複合年增長率(CAGR)為12.7%。
北美將繼續保持其領先區域市場的地位,預計到 2024 年將佔 59.26% 的市場佔有率。這主要得益於先進患者監護系統的廣泛應用、慢性阻塞性肺病 (COPD) 和心臟病的高發病率以及完善的醫療保健基礎設施。 Masimo、美敦力、飛利浦和 Nonin 等主要廠商的存在,也進一步鞏固了該地區的領先地位。
市場動態
驅動因素:呼吸系統疾病日益增加
慢性呼吸道疾病(例如 COPD、氣喘、肺癌、睡眠呼吸中止症和先天性心臟病)在全球的盛行率不斷上升,持續推動對精準血氧飽和度監測的需求。例如,根據美國的數據,大約每 100 名嬰兒中就有 1 名患有先天性心臟病 (CHD),其中 25% 的患兒被診斷為重度先天性心臟病,需要持續進行 SpO2 監測。 患者數量的增加凸顯了脈搏血氧儀探頭在醫院、急診護理和家庭醫療保健環境中的關鍵作用。新冠肺炎疫情進一步提高了全球對氧氣監測的認識,推動了脈搏血氧儀在2020年至2021年間的空前普及。隨後,市場在2022年趨於正常,並在2023年第三季強勁復甦。
限制因素:數位化替代方案的崛起
市場面臨來自新興技術的壓力,例如配備血氧飽和度感測器的智慧手錶、基於智慧型手機的監測應用程式以及具有多重追蹤功能的可穿戴健康設備。蘋果、三星和Alphabet等公司正在加速將氧氣測量功能整合到消費性電子設備中,這給傳統的脈搏血氧儀探頭帶來了激烈的競爭。
挑戰:準確性與監管
人們仍然對準確性感到擔憂,尤其是在膚色較深的人群中。 根據FDA的調查結果,脈搏血氧儀讀數低於90%的情況差異很大,實際飽和度可能在86%到94%之間。監管機構正在製定更嚴格的指導方針,迫使製造商提高探頭的靈敏度和校準技術。
機會:新興經濟體醫療保健基礎設施的擴展
像印度這樣的國家正在大力投資醫療保健現代化,政府已宣布一項68億美元的信貸激勵計劃,以擴展基礎設施。這些措施正在推動對包括脈搏血氧儀探頭在內的監測設備的需求,為全球和本地製造商創造長期機會。
市場趨勢
探頭技術的進步,包括無線連接、人工智慧賦能的精準度以及與行動裝置的增強相容性,正在重塑市場格局。 BioIntelliSense 獲得 FDA 批准的 SpO2 晶片組等創新產品,能夠針對各種膚色和患者活動提供精準的讀數,凸顯了業界向更智慧、更可靠的監測工具轉型的趨勢。
遠距病患監護、遠距醫療和家庭護理的興起進一步推動了對易於使用的消費級探頭的需求。醫院和診所也不斷升級到更先進的可重複使用和一次性感測器系統,以提高感染控制和診斷準確性。
2024 年,可重複使用探頭憑藉其耐用性、成本效益和在大型醫療機構的廣泛應用,佔了最大的市場佔有率。隨著醫院將感染控制放在首位,一次性探頭的市場佔有率正在迅速增長。
成年人是最大的年齡族群,這主要是由於慢性阻塞性肺病 (COPD) 和心臟病的高發生率。 同時,兒科對新生兒監護的需求持續成長。
在測量部位方面,指尖探頭因其易用性、價格優勢以及在各種醫療環境中的廣泛適用性,在2024年佔主導地位。
醫院和門診手術中心繼續保持其作為主要終端使用者的地位,這得益於手術量和重症監護病房入院人數的增長。
到2024年,北美將佔全球市場10.6億美元的佔有率,憑藉其先進監護技術的高普及率,繼續保持領先地位。
歐洲將佔相當大的佔有率,這得益於其強大的臨床基礎設施和日益加重的慢性病負擔。
亞太地區是成長最快的地區,這得益於醫療保健的快速發展、重症監護病房容量的增加以及呼吸系統疾病病例的增加。
在醫療保健投資不斷擴大的支持下,拉丁美洲、中東和非洲預計將保持穩定成長。
細分:年齡層、最終用戶、測量尺寸、最終用戶、地區
依產品類型
依年齡組
按測量部位
按最終使用者
按地區
The global pulse oximeter probes market continues to expand as respiratory health monitoring becomes a critical part of modern healthcare systems. In 2024, the market was valued at USD 2.70 billion, driven by the increasing prevalence of respiratory and cardiovascular diseases, higher surgical volumes, and a rising elderly population. Advancements in non-invasive patient monitoring technologies and the shift toward home-based care have also accelerated product adoption. In 2025, the market is projected to grow to USD 3.02 billion, reflecting strong demand across hospitals, ambulatory surgery centers, and home healthcare settings. By 2032, the market is expected to reach USD 6.99 billion, exhibiting a strong CAGR of 12.7% during the forecast period.
North America remained the dominant regional market in 2024 with a 59.26% market share, supported by widespread adoption of advanced patient monitoring systems, high prevalence of COPD and cardiac diseases, and well-established healthcare infrastructure. The presence of major companies-including Masimo, Medtronic, Philips, and Nonin-continues to strengthen the region's leadership position.
Market Dynamics
Drivers: Rising Burden of Respiratory Diseases
The increasing global prevalence of chronic respiratory conditions such as COPD, asthma, lung cancer, sleep apnea, and congenital heart defects continues to drive demand for accurate oxygen saturation monitoring. For instance, U.S. data shows that CHDs affect roughly one in 100 infants, with 25% diagnosed with critical congenital heart defects requiring continuous SpO2 monitoring. This rising patient volume underscores the essential role of pulse oximeter probes in hospitals, emergency care, and home health setups. The COVID-19 pandemic further expanded global awareness of oxygen monitoring, leading to unprecedented adoption of pulse oximeters during 2020-2021 before the market normalized in 2022 and recovered strongly by Q3 2023.
Restraints: Emergence of Digital Alternatives
The market faces pressure from emerging technologies such as smartwatches with SpO2 sensors, smartphone-based monitoring apps, and wearable health devices capable of multi-parameter tracking. Companies like Apple, Samsung, and Alphabet have accelerated the integration of oxygen measurement into consumer devices, creating strong competition for traditional pulse oximeter probes.
Challenges: Accuracy and Regulatory Scrutiny
Accuracy concerns-particularly for individuals with darker skin pigmentation-remain a challenge. According to FDA insights, pulse oximeter readings below 90% can vary considerably, with true saturation levels ranging between 86-94%. Regulatory bodies are working toward stricter guidelines, prompting manufacturers to improve probe sensitivity and calibration technology.
Opportunities: Expanding Healthcare Infrastructure in Emerging Economies
Countries such as India are investing heavily in healthcare modernization, with the government announcing a USD 6.8 billion credit incentive program for infrastructure expansion. Such initiatives are boosting demand for monitoring devices, including pulse oximeter probes, creating long-term opportunities for global and local manufacturers.
Market Trends
Advancements in probe technology-such as wireless connectivity, AI-enhanced accuracy, and improved compatibility with mobile devices-are reshaping the market. Innovations such as BioIntelliSense's FDA-cleared SpO2 chipset, capable of accurate readings across diverse skin tones and during patient movement, highlight the industry's shift toward smarter, more reliable monitoring tools.
The rise in remote patient monitoring, telehealth, and home-based care is further supporting demand for consumer-friendly probes. Hospitals and clinics also continue upgrading to more advanced reusable and disposable sensor systems to improve infection control and diagnostic precision.
The reusable probe segment accounted for the largest share in 2024 due to durability, cost-efficiency, and widespread use in high-volume healthcare facilities. Disposable probes are growing rapidly as hospitals prioritize infection control.
Adults constituted the largest age-group segment, driven by high COPD and cardiac disease incidence, while pediatric demand continues to rise for neonatal monitoring.
Finger-based probes dominated the measurement site segment in 2024 due to ease of use, affordability, and broad suitability across care settings.
Hospitals and ambulatory surgery centers remained the leading end-user segment, supported by rising surgical volumes and intensive care admissions.
North America accounted for USD 1.06 billion of the global value in 2024, maintaining leadership due to high adoption of advanced monitoring technologies.
Europe holds a significant share, backed by a strong clinical infrastructure and rising chronic disease burden.
Asia Pacific is the fastest-growing region due to rapid healthcare development, increasing ICU capacity, and growing respiratory disease cases.
Latin America and the Middle East & Africa are witnessing steady growth supported by expanding healthcare investments.
Conclusion
With the market advancing from USD 2.70 billion in 2024 to a projected USD 6.99 billion by 2032, pulse oximeter probes will remain integral to global patient monitoring. Rising chronic diseases, technological innovation, and expansion of home healthcare services position this market for strong, sustained growth throughout the forecast period.
Segmentation Age Group, End-User, Measurement Size, End-user, and Region
By Product Type * Disposable
By Age Group * Adults
By Measurement Site * Forehead
By End-user * Hospitals and ASCs
By Geography * North America (By Product Type, By Age Group, By Measurement Site, By End-user, and By Country)